CrossrefInfokarte
Efficacy and Safety of Continuing Bevacizumab beyond Disease Progression plus Docetaxel in Patients with Non-Small Cell Lung Cancer: A Retrospective Analysis
Advances in Lung Cancer · 2015
DOI: 10.4236/alc.2015.41002 ↗Abstract
Kein Abstract verfügbar.
EUVIMED